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Executive Summary  
The goal of this project was to develop a portable, reliable, and robust oxygen provision device.                
The device must be appropriate to treat neonates experiencing RDS and hypoxia in             
low-resource clinical settings, specifically in Nepal. Using the target product profile (TPP)            
developed by UNICEF and NEST360°, we created a list of stakeholder requirements and             
engineering specifications that are the foundation of the problem definition.  
With detailed research and stakeholder interviews, we furthered our understanding of the            
maintenance, training materials, and use of such a device. The method of oxygen concentration              
is the most vital component of the proposed solution, so concept generation focused on this.               
Concept generation strategies including a morphological chart and TRIZ triggers produced five            
unique designs based around five different. Through an evaluation process supported by a pugh              
chart comparison, vacuum swing adsorption (VSA) was selected as our final oxygen            
concentration method. The final design was built around a vacuum swing adsorption system,             
with a simple user interface in portable housing. The design was modeled in SolidWorks.  
Theoretical analyses were run on the VSA system to determine the necessary number of sieve               
beds and identify ways to simplify the user interface. Through research and meetings with              
subject matter experts we determined that there was no obvious barrier to a small scale VSA                
portable oxygen concentration. In detail we performed five engineering analyses: expert           
interviews, sieve bed analysis, cost analysis, risk analysis, and user interface analysis. The five              
analyses supported the theoretical feasibility of the VSA design.  
To verify the solution, a prototype made of a retrofitted pressure swing adsorption (PSA) oxygen               
concentrator was planned. However, due to the coronavirus pandemic, the team was unable to              
meet in person and safely modify the PSA concentrator. Instead, solution verification consisted             
of updates to the theoretical usability and cost analysis, along with test plans detailing the PSA                
retrofit and testing. To better understand next steps that would have to be considered after a                
working prototype is developed, the team met with Randy Schwemmin from the Center for              
Socially Engaged Design to understand the overhead costs of obtaining a CE mark or FDA               
approval and bringing devices to low resource settings. In the case that a prototype proved to                
have a cheaper component cost than current PSA systems with the same functionality, it would               
be worthwhile to pursue a CE mark or FDA approval to make this device available in low                 
resource markets, including Nepal. 
 
When designing medical devices for low-resource settings, it is especially important that health             
solutions are evaluated critically as individuals cannot afford to invest in ineffective treatments             
[3]. Therefore, there should be high importance placed on both the safety and efficiency of               
proposed oxygen concentration devices. Because of the low-resource target demographic of the            
solution, medical and health claims will be appraised critically through the design process. The              




safety standards and serve their patients effectively. The solution verification indicates that it             
may be possible to create a VSA system at a cheaper cost than a PSA system. Physical testing                  
will be necessary to substantiate this theory and push the design on towards validation. 
 
Problem Description and Background  
Approximately 1 in 10 newborns require immediate assistance breathing after birth due to             
improper formation of lungs [5]. In the womb, a fluid called surfactant is built up in the fetus’s                  
lungs. This surfactant is responsible for reducing surface tension in the lungs, allowing for the               
lungs to be inflated more easily. A diagram of this is illustrated in ​Figure 1 below. After birth, this                   
fluid is absorbed into the neonate’s lungs as they begin to breathe with their fully expanded                
lungs. This process is reflexive and must occur directly after birth, i.e. the “baby’s first breath”. If                 
the amount of surfactant in the lungs is insufficient and the lungs are not fully expanded, then                 
neonate may struggle to take the first breath, leading to Respiratory Distress Syndrome             
(RDS).Surfactant production begins in week 24 of pregnancy. Neonates born before 24 weeks             
gestational age all have RDS [5]. By 34 weeks gestation age, most neonates have produced               
enough surfactant to survive on their own. Despite this, some neonates born after 34 weeks and                
even full term neonates can suffer from RDS. If the RDS remains untreated, it can lead to                 
hypoxia, or oxygen deprivation in organs and tissues, causing further complications. Nepal, with             
a neonatal mortality rate of 27.9 per 1000, is ranked 17th in the world for neonatal mortality [37].                  
Of all neonatal deaths in Nepal, the largest sector of deaths are complications from preterm               
birth, including respiratory distress syndrome [38]. 
 
Figure 1: ​Fetal respiratory system development, and surfactant build up. [5] 
Current Solutions 
Newborns with Respiratory Distress Syndrome can be treated with artificial surfactant or with             
supplemental oxygen. These artificial treatments of surfactant for one patient can range in cost              
from $800 to $1200 [34]. In Nepal, many hospitals, including that of our main stakeholder Dr.                
Stephen John, do not have wall oxygen. Dr. John’s hospital uses portable oxygen concentrators              




they do however have some obstacles. Portable oxygen concentrators cost above $1500 and             
only treat one patient [16]. If such a concentrator could take more patients, or cost half as much,                  
a hospital could double its capacity to treat infants in respiratory distress. It is our goal to create                  
an effective and low cost oxygen concentration device to treat neonates experiencing RDS and              
hypoxia in low-resource settings such as Nepal. The currents standard in portable oxygen             
concentration are pressure swing adsorption oxygen concentrators. 
Pressure Swing Adsorption 
Overview 
Current oxygen concentrators operate on a Pressure Swing Adsorption (PSA) system. When            
gasses are pressurized, different gasses are attracted to solids more or less than others. PSA               
systems utilize this and pressurize air to attract gasses to the molecular sieve beds in the                
system [31]. This process can be seen in oil refineries for carbon dioxide removal in hydrogen                
gas production, methane concentration to produce biogas similar to natural gas, and in hospitals              
for oxygen concentration as a substitute for oxygen tanks.  
Portable Oxygen Concentrators 
Portable oxygen concentrators (POC) are similar to the systems that can be found in hospitals               
for bulk oxygen generation but on a smaller scale. POCs work by intaking ambient air and                
filtering it through a two stage filter. The first stage is a Cyclone High Efficiency filter meant to                  
remove large dust particles and other contaminants while the second stage is a High Efficiency               
Particulate filter which is responsible for eliminating the smaller sized contaminants [31].  
The filtered air is then pushed into a compressor and a dryer to produce pressurized air without                 
any excess moisture generated from the change in temperature and pressure. This clean air is               
now ready to enter the molecular sieve beds. For oxygen concentration, zeolite is often used               
because of its strong attraction to nitrogen at high pressures. These beds adsorb the nitrogen               
resulting in air that has higher oxygen concentration than atmospheric air. The air is removed               
from the beds and placed into tanks for further processing. A simplified diagram of this entire                
process can  be seen in ​Figure 2 ​below. 
 




For the process to begin again, the beds are depressurized allowing for the nitrogen to detach                
from the zeolite. Some of this air is removed as exhaust back into the environment while the rest                  
of it is used to pressurize the other molecular bed in a process known as pressure equalization.                 
The usage of more than one bed allows for the continuous production of oxygen concentrated               
air.  
Benchmarking 
Current solutions for newborns with RDS are similar for both high and low resource settings. As                
part of the design process, we compared current portable oxygen concentrators in the market              
and other projects that either tried to serve low resource settings or tried to serve a need for                  
portable oxygen. To better illustrate why these solutions do not meet the requirements of our               
stakeholders, we selected a few high and medium priority specifications from our project and              
marked whether or not these alternatives are viable options. All benchmarks found used             
pressure swing adsorption as described above to achieve oxygen concentration. The table can             
be seen below in ​Table 1. 
 
Table 1: ​Comparison of current oxygen concentrator solutions. Details regarding the 
requirements can be found under “Requirements and Specifications” on page 6 
 
Green: ​Optimal requirement is satisfied 
Yellow: ​Minimal Requirement is satisfied 
Red: ​Neither requirement is satisfied 
 
Inogen One G4’s ​portable oxygen concentrator claims to be the most portable POC available;              
however, its lightweight components make for a more expensive unit, exceeding the required             
$1,600.00 limit. Its size also limits the number of users per device which is not ideal pricewise.  
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Inogen One G4 POC with 
Pulse Dose Flow [14] 
      
Inogen at Home [31]       
O2 Concepts Oxlife 
Independence POC [15] 
      
OxCart (Rice University) [3]       
OGSI (OG-15 and OG-20) 
[8] 
      
 
 
Inogen at Home ​provides sufficient oxygen at proper concentrations, but it is meant for              
stationary use only. This limitation may make it difficult to deliver to the hospitals in Nepal and                 
will not allow for users to continue oxygen treatment in their homes.  
O2 Concepts’ ​portable oxygen concentrator is similar to that of ​Inogen One G4’s ​product. Their               
product boasts extended battery life but at the cost of expense which is a higher priority                
requirement.  was not designed with our specific stakeholders in mind.  
OGSI’s ​oxygen concentrator is another device that is catered more for communities outside of              
the one we were tasked with designing for. Although it generates the proper oxygen              
concentration and can be used on multiple users at a time, it is not portable. 
No benchmarked concepts meet all the listed requirements. Inogen and O2 Concepts achieved             
all technical requirements without achieving the cost. Therefore we know that the technical             
requirements are achievable, and our primary goal will be to decrease cost. 
Stakeholders 
There are multiple stakeholders for this project. Dr. Stephen John, is one of the most important                
stakeholders and sponsors. He serves as a technical mentor for our team, is the co-founder and                
CEO of Aim Tech and a pediatrics resident for internal medicine. He has helped make NeoVent,                
an ultra-low cost, easy to use, energy efficient respiratory device for infants in respiratory              
distress. Stephen is especially invested in this project due to the applications that it can have                
with NeoVent and in Nepal. The University of Michigan, as well as Caroline Soyars, a global                
health sponsor, are also stakeholders and sponsors, as this project is not only applicable to               
low-resource settings, but can also be applied to more developed countries. The World Health              
Organization (WHO), as well as the United Nations Children's Fund (UNICEF) are stakeholders,             
as the need for oxygen treatments are at an all time high, especially during the COVID-19                
pandemic. Parents of newborns with RDS are also stakeholders, as this project aims to create a                
more affordable treatment. The Kwame Nkrumah University of Science and Technology           
(KNUST) in Ghana is also a stakeholder. The student team at KNUST is also working on a                 
similar project with connections to local research hospitals there in Ghana. This is very              
important to them because Ghana is one of the low-resource environments where a viable              
solution is needed most.  
Subject Matter Experts 
In addition to our stakeholders, meeting with subject matter experts from a variety of fields and                
backgrounds will help us broaden our knowledge on low resource settings, infant care and RDS,               




From the Clinical Simulation Center (CSC) at the University of Michigan School of Nursing, Ms.               
Debra Yake, Training Specialist; Dr. Deb Rooney, PhD; and Mr. Ed Lockett III, Simulation              
Technician, have helped us understand how doctors, nurses, and clinicians are trained on new              
devices. Deb Rooney is the CSC’s Director of Education and Research where she has over 25                
years of medical education experience, with the last 12 being in simulation. Debra Yates is a                
training specialist and course director with the CSC.  
From the Center for Socially Engaged Design at the University of Michigan, Mr. Randy              
Schwemmin has knowledge on medical device manufacturing and costs associated with that.            
We hope to gain understanding on the current costs associated with oxygen concentrators, and              
where in the manufacturing and distribution those costs lie.  
From the Chemical Engineering department, Mr. J.T. Anyanwu is the graduate student of Dr.              
Ralph T. Yang who has done research on cyclic adsorption processes such as PSA as well as                 
adsorbents and diffusion in zeolites. From Mr. Anyanwu, we gained valuable insight on vacuum              
swing adsorption and its feasibility on a small-scale. 
Dr. Jeff Plot is the Associate Director of Engineering and Development, Biomedical Engineering,             
at the University of Michigan. We plan to use his experience with medical device product               
development to validate our current design. 
Throughout the project, we will continue to seek advice from subject matter experts, especially              
as we seek to delve deeper into low resource design and constraints specific to hospitals in                
Nepal. 
Requirements and Specifications 
Overview 
A report [3] summarizing the consensus achieved at a meeting regarding Target Product             
Profiles(TPP) for newborn care in low income settings was written by a professor from              
Northwestern. The meetings held for this TPP involved individuals from UNICEF, NEST360°            
and other stakeholders. Many of the requirements and specifications from the TPP were             
adopted and applied to our project.  
 
The current list of requirements will grow as meetings with stakeholders provide further             
information. Dr. John [16] will also be a valuable source of information given his experience in                
the medical field in Nepal. These meetings will include individuals from the Kwame Nkrumah              
University of Science and Technology (KNUST) who are working on a similar project and have               
access to a hospital in Ghana, giving them greater insight on the needs of hospitals in these                 




To cater our work towards low resource hospitals in Nepal, we have reconsidered all              
requirements from the Target Product Profile, refined them, made them more specific to Nepal,              
and prioritized them based on the input of our stakeholders.  
High Priority 
From stakeholder feedback and the target product profile, we have identified the requirements 
and specifications with the greatest priority, listed in Table 2 on page 6. 
 
Table 2:​ Highest Priority Requirements and Specifications 
Green: ​ High Understanding 
Yellow: ​Growing Understanding 
Red: ​Incomplete Understanding 
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Requirement  Specifications   
Be able to provide sufficient oxygen           
[31] 
The concentrator must provide 93% FiO2 with a 3% contingency                   
[31] 
Be safe [31]  The device must meet either approval guidelines for USFDA or                   
other stringent regulatory body of a founding member of IMDRF [31] 
Be cost-effective [31] [32]  Optimally, the device should cost less than 500 USD 
 
Minimally, the device must cost less than 1,600 USD [31] 
Be able to maintain a low flow rate               
[31][16] 
The concentrator’s minimal flow rate must not be higher than 0.5                     
LPM (optimal)/2 LPM (minimal requirement) [31] 
Be modular [31] [23]  The device must use a standard ribbed conical connector to                   
interface with a variety of oxygen delivery methods [31] 
 
Compatible with standard outlet/inlet connectors (22 mm outer               
diameter) and flex adapters [23] 
Be usable by a minimally trained user             
[31][16] [15] 
To show current state of oxygen concentration and warnings                 
pertinent to patient condition and device condition: 
● The visual display should be at contrast ratio >7:1 and luminance                     
>35 cd/m​2 with a font size >16 to make it easily visible at a                           
distance of 3 ft. The visual warning/indicator lights should be red                     
or green. [15] 
● The auditory warning should be approximately 89 dB and 127                   
sones. [15] 
 
No specialized tools may be required for day to day operation [31] 
 
The device should be usable after a 5 minute training video. [16] 
 




Provide Sufficient Oxygen 
Of high priority, the oxygen concentrator solution must be able to provide sufficient oxygen for               
the neonates. This specification is 93% FiO2 ±3%, that is 93% pure oxygen, as defined by the                 
Target Product Profile [31]. 
Be Safe 
In designing medical devices, safety of the users is of the utmost importance and high priority.                
Thus, adequate safety of the solution is defined as meeting either approval guidelines for              
USFDA or other stringent regulatory body of a founding member of IMDRF [31]. 
Be Cost-Effective 
Of similar high priority, the cost of the oxygen concentrator solution should be lower than current                
oxygen concentrators to ensure its affordability in low-resource settings. Optimally, the device            
should cost no more than 500 USD; however, at minimum the device should cost less than                
1600 USD [31]. As mentioned earlier in benchmarking, the existing solutions that are able to               
provide sufficient oxygen concentration are currently above this price level. The Inogen at home              
meets our minimum cost requirement but is not an optimal solution. 
Be Able to Maintain a Low Flow Rate 
When delivering oxygen to an infant, doctors decide the percentage of oxygen and the flow rate                
at which the oxygen is delivered to the infant based on the infant’s specific situation. Doctors                
can modulate the percentage of oxygen by diluting the 93% oxygen directly from the              
concentrator with room air. To achieve the desired oxygen percentage at a proper flow rate, it is                 
important to have precise control over the flow rate at which the 93% oxygen is delivered.                
Optimally, the oxygen can be delivered at a rate of 0.5 LPM, at the lowest [31]. Minimally, the                  
oxygen will be able to be delivered at 2 LPM [31]. Through stakeholder input, we have                
determined that one user will be treated by each device [16]. 
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understandable to hospital staff as well as parents with no training                     
time, so that they know when to alert a hospital staff member. 
Be able to operate in a variety of               
extreme environments common to       
Nepal [31] 
The device should not need more than quarter-annual preventive                 
maintenance. 
 
The device must operate up to 2000m above sea level.  
 
10°C < Operating Temp < 40°C 
 
15% < Operating Relative Humidity < 95% 
 




In order to get the most use out of the oxygen concentrator, it should be modular, meaning it                  
should be able to work with a variety of ventilators, masks, and nasal cannulas [31]. According                
to guidelines from the WHO on ventilator design, this means the concentrator should be              
compatible with standard inlet/outlet adaptors of 22 mm outer diameter [23]. This requirement is              
still developing as we learn more about the ventilation devices available at the location we are                
designing the concentrator for. 
Be Usable by a Minimally Trained User 
To maximize the accessibility of the concentrator, it should be usable by a minimally trained               
user. This means the device should require minimal training time and no specialized tools for               
day to day operation [3]. The training time is defined as being usable after a 5 minute training                  
video which is an acceptable time target given to us by Dr. Stephen John [16]. The device                 
should also have clear visual and auditory warnings and displays. Through research on human              
factors we found this means the visual display should be at contrast ratio >7:1 and luminance                
>35 cd/m2 with a font size >16. The visual warning/indicator lights should be red or green and                 
the auditory warning should be approximately 89 dB and 127 sones [15]. The visual display               
requirements were made to be easily visible at a distance of about 3 ft which is appropriate for a                   
bedside device. Any alerts on the device should be able to be interpreted by hospital staff as                 
well as an untrained person so parents are able to understand and notify hospital staff when                
there are warnings. 
Operational in Extreme Environments 
In general, low resource hospitals face more extreme environmental stressors because they            
may not have climate control or reliable climate control. In addition, part of the Himalayan               
mountain range falls in Nepal and has major population centers as high as 1700m above sea                
level. Given Nepal’s geography and climate, it is critical that our device operate in temperatures               
between 10°C and 40°C, relative humidity ranging between 15% and 95%, and function at              
elevations up to 2000 m [31]. Based on further research, there are no hospitals above 2000m in                 
Nepal. In specific, the hospital of our stakeholder Dr. John lies at 1500m above sea level. 
Medium Priority 
There are quite a few requirements and specifications that are not ranked quite as highly in 
terms of importance by our stakeholders. These requirements are listed below in Table 3. 
 
Table 3: ​Medium Priority Level Requirements and Stakeholders 
Green: ​ High Understanding 
Yellow: ​Growing Understanding 




Begin Operation Quickly 
The oxygen concentrator is meant to provide oxygen to newborns in cases when they cannot               
breathe on their own. This means every second it takes to start up the device, the newborn has                  
to survive longer with improperly formed lungs. Although it is essential for the device to start up                 
quickly in the scenario mentioned above, it is expected for the device to be set up and ready to                   
provide oxygen at any given time. Hardly ever should the device setup begin at a moment’s                
notice of the newborn’s condition.  
Be Transportable 
It is ideal for the device to be set up and ready to go in the room it will be needed; however, if                       
the device needs to be moved to another part of the hospital, it is ideal for the oxygen                  
concentrator to be moveable by one person. Since we are designing for a hospital setting, we                
do not have to factor in any potential rough terrain. In a setting such as the hospital, it is                   
essential to reduce the number of staff members required per operation.  
Simple Maintenance 
To perform its life saving function, the oxygen concentrator must be reliable. In order to avoid                
burdening staff at low resource hospitals, it must be easy to maintain. No specialized tools               
should be needed for both regular operation and maintenance - all tools required should be               
already owned by the hospital for maintenance on other equipment. Thus, we can assume the               
use of phillips and flathead screwdrivers along with basic hand tools. No specialized torque              
screws may be required [16]. Procedures should be simple so that preventive and emergency              
maintenance can be communicated in a 5 minute video. This time target was also provided by                
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Requirement Specifications 
Be able to start working quickly [31] The concentrator must be able to reach 95% of 93% FiO2           
and 10 LPM flow rate in less than five minutes [31] 
Be transportable by a single hospital staff       
member [31] [16] 
Weight < 30 kg [16] 
 
The unit must be movable with at least two wheels [31]  
Device maintenance should be simple [31] No specialized tools required. 
 
Fixable by a biomedical technician after a 5 minute training          
video. 
 
Filters are easy to wash and replace. 
 
Attachments must be removable so the device is simple to          
sanitize between patients. 
 
The device must not require preventative maintenance more        
than four times per year. [31] 
 
 
Dr. Stephen John [16]. While the device should be very durable and rarely need emergency               
maintenance, it is important that it also only needs preventative maintenance four times a year               
or less as stated by the TPP [13]. The filters, which will need to be regularly switched, should be                   
reusable and simple to wash and change.  
Low Priority 
There are two lower priority requirements as prioritized by our stakeholders and the Target 
Product Profile, shown in ​Table 4​. 
 
Table 4: ​Low Priority Requirements and Specifications 
Green: ​ High Understanding 
Yellow: ​Growing Understanding 
Red: ​Incomplete Understanding 
Be Quiet 
In order to create a product that is pleasant to the senses, the device must be quiet. The                  
specification for this is that the ambient operating noise be less than 50 dB. The noise of the                  
device does not affect the functionality, it is strictly for customer satisfaction.  
Be Operable in Nepal 
Given that our main stakeholder, Stephen John, is primarily focused on working with neonates              
in Nepal, we have decided to focus our efforts there. In order for the device to function properly,                  
the specifications are that it must consume less than 275 W at 5 LPM. The device also has to                   
operate properly on Nepal’s power grid. Which means it must operate on a 230V supply voltage                
at 50Hz, and have a type C, type M, or type D connector.  
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Requirement Specifications 
Be quiet [31] Ambient operating noise < 50 dB [31] 
Be operable in Nepal [31] [16] [15] The device uses mains power.  
Power consumption <275W at 5 LPM  
The Voltage model must match the voltage and frequency of          
the purchasing country’s local power grid. 
Nepal operates on a 230V supply voltage and 50Hz [15] 
Type C, Type M, Type D connectors  
 
 
Solution Neutral Considerations 
Since the oxygen concentrator will be used in a low-resource setting for the purposes of               
healthcare, there are some environmental and ethical factors we have to consider. These aren’t              
requirements that can be described with quantified specifications but considerations that will            
influence our design space. There is a possibility that the device will be used in patient homes                 
so we must consider various backgrounds and levels of education to maximize the accessibility              
of the concentrator. The device will be used for the purpose of healthcare so we want it to abide                   
by the principle of “Do No Harm” which in this case would mean to avoid disease transfer via the                   
oxygen concentrator, both synchronously if more than one patient were to be receiving oxygen,              
and asynchronously between patients. We’ll have to consider emotional stressors between the            
carer and infant as well environmental stressors such as patient density within the hospital. We               
mentioned cost above from the perspective of the hospital being the purchaser but we should               
also consider what the patients at the hospital can afford for healthcare. 
Concept Exploration 
Concept Generation and Development 
Methods and Rationale 
Three design tools were used to generate solution concepts: a design space map, a              
morphological chart, and TRIZ triggers. The design space map was chosen to give us a               
physical representation that might allow us to recognize unexplored aspects of oxygen            
concentrator designs. A morph chart, with its organization of concepts by function, allowed us to               
view the oxygen concentrator as four smaller problems based on individual functions. Because             
an oxygen concentrator can include complex chemical, mechanical, and electrical subsystems,           
our generation approach needed to be research based. The TRIZ effects database allows users              
to search general solutions by function, parameter, or transform. Having broken down the             
oxygen concentrator into four basic functions for the morph chart, we ran a generalized              
restatement of each function though the TRIZ effects database and focused our research on              
promising ideas listed there for each function [36].  
Results 
The design space map was of limited use to us, we were unable to imagine much outside the 
confines of the current oxygen concentration method, PSA. The morph chart allowed us to 
expand more by function, and we were able to brainstorm creative ideas for the following four 
functions: Raw Material Intake, Oxygen Purification, Air Formatting, and Air Delivery. After 
brainstorming for each function, we used the TRIZ triggers to find more ideas for each function 




Table 5: ​Morphological Chart showing solution concepts for the four subproblems 
 
Some ideas were mutually exclusive to ideas in other categories, meaning they could be applied               
to any solution from a different category. For example, a mechanical valve for air formatting can                
be applied to any oxygen filtration solution. Other ideas were less so: using water as the raw                 
material for intake only works with the electrolysis oxygen concentration concept. In general, the              
raw material intake is dependent on the oxygen purification method and cannot be varied.  
Using these constraints and significant research, we identified five unique solutions from the             
morphological chart as shown below in ​Table 6​. Oxygen concentration was determined to be              
the key design function, so the team focused on this function for concept selection, prioritized               
over the other solution sub-functions. This led us to center our solutions around the five different                
methods for oxygen purification: Semi-Permeable Membrane, Electrolysis, PSA, VSA, and          
VPSA. ​Table 6 shows the raw material intake associated with each oxygen purification method.              
After the oxygen is purified, the next step is to format the air for delivery. This part of the solution                    
is independent of the oxygen purification method. For this step, we plan on having a mechanical                
valve which will allow ambient air to be reintroduced to the system. This gives us control of the                  
exact oxygen concentration of air that is being delivered to the patient. When the air is being                 
delivered out, we want the solution to be compatible with as many ventilation devices as               
possible. To achieve this, we decided the delivery method would take the form of a universal                
standard adapter. 








Electrolysis is a process in which water undergoes decomposition into hydrogen and oxygen 
gas via an electric current as shown in the simplified diagram in ​Figure 3​ below[39]. Currently, 
electrolysis is used mainly for hydrogen generation in appliance sized electrolyzers for 
lower-scale hydrogen production and large-scale, centralized hydrogen production facilities for 
energy production[39]. Using electrolysis for oxygen generation, especially on a portable scale, 
has not been commercialized. One of the few industries engaging with this technology is the 
aerospace sector, where oxygen generation via electrolysis has been used to supply space 
stations with necessary oxygen levels[20]. 
 
Figure 3: ​Electrolysis Overview [21] 
Oxygen Concentration 
In the proposed electrolysis design water will be pumped into the device from an external 
source. Oxygen is generated when electricity is run through the water, decomposing water into 
hydrogen and oxygen gas. The resulting concentration of oxygen is extremely high, greater than 
97%[20]. 
Benefits of Electrolysis 
The high concentration of oxygen produced via electrolysis is a major benefit to the system, 
surpassing the requirement of 93% oxygen. However, electrolysis is expensive, especially in 
terms of the electricity required to run it. Additionally, the system does not lend itself well to 
portability as it must be connected to both a power supply and a water source. The oxygen 
concentration system also raises safety concerns, as the produced hydrogen gas potentially 




Semipermeable Membrane  
Overview 
Semipermeable membranes employ the physical differences between molecules in the air to 
filter out undesirable molecules by size as shown in ​Figure 4​. Currently, semipermeable 
membranes are used for nitrogen concentration, shunting oxygen, argon, and all other air 
components off while allowing nitrogen molecules through. This method provides nitrogen for a 
variety of industries such a metallurgy, oil and gas, electronics, and medicine, and allows these 
industries to operate independently of the liquid nitrogen supply chain [25]. In general, 
membrane based gas separation methods are lower fidelity than zeolite based methods, 
however very successful air to concentrated nitrogen solutions exist, so it is possible that this 
method could be reversed to leave nitrogen as the byproduct and filter for oxygen [25, 33]. 
 
Figure 4: ​Current nitrogen concentration via a semipermeable membrane [25] 
Oxygen Concentration 
The Semi-permeable membrane method requires ambient air be taken in via a compressor. The 
ambient air is filtered before entering the system and goes through heating and cooling to 
remove excess moisture from the air before it is ready to be separated. Directional filters 
directional filters should select for oxygen molecules along the grain and shunt all other 
molecules, especially nitrogen molecules, off into the byproduct stream [25].  
Benefits of Semipermeable Membrane 
The semipermeable membrane is a physical solution that does not rely on a chemical reaction 
or, therefore, the chemical reactants needed for that reaction. Air must be very clean before 
passing through the membrane, but given this condition, it may be possible to develop a 




Vacuum Swing Adsorption System 
Overview 
Vacuum swing adsorption systems (VSA) are similar to pressure swing adsorption systems in 
that they use molecular sieve beds, more specifically zeolite, to filter out the unwanted 
molecules in air to concentrate oxygen. VSA systems are currently used to generate oxygen, 
treat wastewater, combustion, and mining [18]; however, there have been very few applications 
of VSA systems in portable oxygen concentrator technology.  
Oxygen Concentration 
VSA systems differ from PSA in that there is no compressor. The air is taken into the system 
using a blower and filtered through the same two-stage filter as before. Once the air is pushed 
through the zeolite, the system swings to a vacuum using a pump to remove the nitrogen from 
the bed and force out the exhaust. A simplified diagram of the process can be seen in ​Figure 5​. 
 
Figure 5:​ ​Portable Oxygen Concentration 
Benefits of VSA  
As mentioned before, this system does not use a compressor. This means the energy 
requirement compared to that of PSA is lower by as much as 50% [18]. The absence of a 
compressor also means the operating temperatures and pressures are much closer to that of 
ambient air. This makes for a safer system that is minimally affected by atmospheric pressures 
and a system that requires fewer parts because of the lack of pressurization. These benefits 
satisfy the requirements regarding operation in extreme environments and simple maintenance. 
  
The molecular sieve beds in a VSA system last much longer than that of a PSA system for 
several reasons. There is no additional moisture added to the air because there is no 
compression. This reduces the amount of contaminants that enter the beds, meaning they do 




nitrogen from these beds which allows for more nitrogen to be adsorbed in the next cycle and 
for more oxygen to enter the system. This more efficient cleaning procedure means VSA 
systems produce more oxygen in the long run than PSA systems do.  
Hybrid Vacuum Pressure Swing Adsorption System 
Overview 
Hybrid vacuum pressure swing adsorption systems (VPSA) are a combination of the PSA and 
VSA systems mentioned above. They operate using both a vacuum pump and compressor. 
Because of the compressor, VPSA systems are best suited for applications that require 
pressures higher than ambient. Otherwise, the additional cost has no real benefit in a portable 
oxygen concentrator [30]. This is the reason why VPSA systems are not commonly applied to 
these devices. 
Benefits of VPSA 
This system combines processes for clearing beds which means more efficient oxygen 
concentration and longer lasting materials. Although there is a higher initial cost because of the 
additional components in the system, operating costs in a VPSA operated POC is lower than 
that of PSA. This, however, does not include maintenance costs which is higher than the 
previously mentioned systems because of the complexity of the device. A simplified version of 
the process is shown in ​Figure 6​ below. 
 





Method and Rationale 
A Pugh Chart was used to evaluate the five possible solutions. Pugh Charts evaluate concepts               
in relation to a baseline concept based on specified criteria. Criteria are weighted, and concepts               
are ranked as being either better or worse than the baseline [35]. This format lent itself well to                  
evaluation of the five solutions proposed; it allowed for evaluation of the four novel solution               
concepts in relation to the current solution. In this way, all ideas were compared to the current                 
standard solution: pressure swing adsorption. This allowed for both identification of the best             
idea and whether or not it improves on the current solution. 
Six criteria were used in the Pugh Chart to evaluate the four novel ideas in relation to pressure                  
swing adsorption. The weighted criteria were designed to simply reflect the requirements and             
specifications in the context process performance, and are as explained below in ​Table 7. 
Table 7: ​Pugh Chart criteria weights 
Cost falls in the category of highest importance in the requirements and specifications. In Nepal               
and other low resource settings, affording sufficient oxygen concentrators is a significant barrier             
to a hospital. In achieving the $500 - $1200 cost goal set by the World Health Organization in                  
the Target Product Profile, we would enable low resource hospitals to purchase more             
concentrators with the same budget, or reduce their budget and send that money elsewhere,              
depending on hospital needs.  
We cannot lose functionality as we bring down cost. Oxygen concentration is also a high               
importance requirement. Any proposed solution must be able to concentrate oxygen to 93% ±              
3%. This requirement comes second only to cost because solutions with proper oxygen             
concentration rates do exist while solutions at affordable cost do not. 
Simple maintenance is a medium importance requirement defined in the Requirements and            
Specifications. Maintenance schedules will greatly impact how useful the device is to the             
hospital: its reliability is paramount. Once the device works and is aquireable at reasonable cost,               
it should require no more than yearly preventative maintenance. 
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Criteria Weight 
Cost 6 (highest weight) 
Oxygen Concentration 5 
Maintenance 4 
Energy Efficiency 3 
Safety 2 
Raw Material Intake 1 (lowest weight) 
 
 
Energy efficiency refers to the ability of the device to concentrate oxygen efficiently so as to not                 
require frequent filter replacement and not consume high power. While this does fall under the               
medium importance maintenance requirement, it has been separated into a separate criteria            
here in light of significant differences between the process. That is to say, one proposed               
process may be robust enough not to require frequent preventative maintenance but is             
inefficient in that it requires a large amount of energy or dirties the filters frequently. 
Safety is a high priority requirement in the requirements and specifications. It is weighted below               
cost, oxygen concentration, and maintenance on the Pugh Chart because we have observed             
that safety does not change heavily between the proposed processes, with the possible             
exception of the electrolysis process. Our largest effort in safety will not be with the differences                
between the four novel solutions, but with a scope decision under consideration: if the oxygen               
concentrator, regardless of concentration method, is used to support more than one patient,             
then disease transfer must be impossible. Since the most important aspect of the safety              
requirement is not directly applicable to the Pugh Chart, we have chosen to prioritize the other                
differentiators for concept selection. 
Raw material intake is listed as a criteria because each process directly influences the possible               
intake methods, so the intake is inseparable from the process. It is weighted least of all criteria                 
as it is not heavily tied to any requirement. Certainly, the raw material used and the intake                 
method must be accessible in environments common to Nepal (a high priority requirement), and              
must allow for a quick start-up time (a medium priority requirement), but there is no indication                
that any method won’t meet either of these two requirements. This criteria exists more so to                
compare the intakes than to eliminate one. 
Results 
 
Figure 7:​ Pugh Chart showing selection of VSA Solution Concept 
Vacuum Swing Adsorption was shown to be the most promising solution across the six criteria 
using the Pugh Chart, outperforming the current solution baseline by 15 points. This is quite a 
large win, with the closest solution, semi-permeable membrane scoring 14 points lower. This 
result is due to VSA’s low cost and greater than or equal to performance to PSA in all other 




concept, as the Pugh chart accurately represents the priorities of the stakeholders to solutions 
that are both low cost and effective. 
Proposed Solution Concept 
The vacuum swing adsorption portable oxygen concentrator solution concept will be modeled            
after current pressure swing adsorption portable oxygen concentrators to help determine           
general size and process flow. The system will be housed in a mobile box no heavier than 5 lbs                   
per current Inogen PSA benchmarks [13, 14] with a pair of wheels and a handle for easy                 
transportation. Ambient air will be brought into the system via a blower, purified to 93% oxygen                
concentration via vacuum swing adsorption, formatted using an air-oxygen blower, and output            
via the conical universal connector. The external clinical interface will include sensors, warnings,             
and user inputs for ambient air and oxygen levels as shown in ​Figure 8 below The model will                  
follow the schematic detailed in ​Figure 5​ on page 19. 
 
Figure 8:​ VSA Portable Oxygen Concentrator Concept 
 
Solution Development and Verification 
Engineering Analysis 
Eight different engineering analyses were used to evaluate whether the proposed vacuum swing             
adsorption system meets specific stakeholder requirements and engineering specifications. The          
analyses include expert interviews, sieve bed analysis, cost analysis, risk analysis, usability            
analysis, filter system, air formatting, and surge tank necessity. The first five modes of analysis               
have been completed and are described in detail. The last three analyses are completed as a                





Expert Interview 1 
Question:​ What are the important features of the concentrator and interface for clinicians? 
Requirement:​ “The device should be usable after a 5-minute training video.” 
The University of Michigan Clinical Simulation Center (CSC) is a learning laboratory that allows              
nurses, physicians and clinicians in training the opportunity to practice skills in simulated ICU              
and hospital environments. In this in person, semi structured interview, Sarah spoke with three              
experts affiliated with the Clinical Simulation Center at the Towsley Center in the UM Hospital.               
Debra Yake, a training specialist, Deb Rooney, PhD, the CSC director of Education and              
Research, and Ed Locket III, Simulation Technician, shared information on medical procedures            
for infants with respiratory distress syndrome and demonstrated the features they use on related              
equipment. Because of their firsthand experience with oxygen concentrators and infants in            
respiratory distress, their input was invaluable to us, and because their experience is so much               
greater than ours, an expert interview to understand the important features medical            
professionals need was warranted. They emphasized the following two things: 
1. Although infants with hypoxia are typically delivered as high an oxygen percentage as             
possible. Ability to vary oxygen concentration is important so that clinicians may use the              
device flexibly for hypoxia as well as other common neonatal respiratory issues, as the              
reason for respiratory distress is not always immediately clear.  
2. Respiratory distress requires very quick reaction time. Ability to set both oxygen            
concentration and flow rate quickly, and to switch delivery devices quickly is of critical              
importance because of the time sensitive nature of hypoxia. 
Our main stakeholder, Dr. Stephen John, confirmed that the ability to vary oxygen would be               
necessary for the Nepalese Clinicians for the same reason. Based on this feedback, our design               
will incorporate a method to vary oxygen concentration in addition to being able to provide 93%                
oxygen concentration, and we will use a Usability Analysis to seek out ways to minimize human                
response times and human error when interfacing with the oxygen concentrator. 
Expert Interview 2 
Question:​ Are there size limits on cyclic adsorption processes that prevent downsizing? 
Requirement:​ “The device must be transportable by a single staff member” 
Portable Oxygen Concentrators have been the subject of study in university labs. At the              
University of Michigan, Dr. Ralph T. Yang in the Department of Chemical Engineering studied              
zeolite-based cyclic adsorption processes in the late 1990s and early 2000s before pivoting to              
research on carbon capture. In a virtual, semi-structured interview with Dr. Yang’s PhD students              




processes involved in adsorption, and the field of portable oxygen concentrators research.            
Because there are so few labs currently affiliated with research in cyclic adsorption processes, it               
was very useful for us to be able to talk to John-Timothy and Yiren. Since this information was                  
not readily available on the internet and we were not able to gather in person to experiment,                 
speaking with somebody who had first had experience helped fill those gaps. We learned many               
things from the interview, including: 
1. Research into cyclic adsorption processes is largely experimental. Simulations are          
complicated and inaccurate, and so most research relies on experiments with a high             
volume of cycles. 
2. Since pressure swing adsorption portable oxygen concentrators were commercialized in          
the 1990s, there has been little to no university research related to different portable              
oxygen concentrator concepts. 
3. The same way that pressure swing adsorption was scaled down to achieve portable             
oxygen concentrators in the 1990s, there is no constraint on the chemical processes that              
prevent a scale-down of vacuum swing adsorption. 
Because of this interview, we pivoted our engineering analysis methods to be primarily             
experimental, using zeolite purification cycle data published online and planning to retrofit parts             
to an existing pressure swing adsorption system. 
Sieve Bed Analysis 
Question:​ How much zeolite is needed to provide the required amount of oxygen? 
Requirement:​ “The device must provide 10L of oxygen per minute” 
There are different forms of zeolite used to absorb different molecules in the air. Most commonly                
used in a portable oxygen concentrator is 13x zeolite. For these calculations, we used LiAgx               
zeolite which is lithium and silver ion exchanged zeolite. We chose this zeolite because it is best                 
for nitrogen removal with 96% oxygen purity and 62% recovery. After the amount of zeolite was                
determined, we can calculate the volume of the molecular sieve beds needed and make              
adjustments as needed. The following table shows the important calculations used to find the              
amount of zeolite needed in kilograms: 
Table 7​: Sieve Bed Analysis Summary 
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Target Oxygen Concentration (%)  93 
Total Recovery of Oxygen LiAgX (%)  62.7 
Cycle Time (sec)  5 
Outlet oxygen needed for 1 user at 10 LPM   10 
Inlet Oxygen (L/min)  15.95 
Inlet Air Mixture (L/min)  79.74 
Inlet Air Feed to each column (L/min)  39.87 
 
 
The mass of LiAgx zeolite needed is low enough to allow the weight of the entire device to fall                   
below the required maximum weight. However, most portable oxygen concentrators use           
molecular sieve beds with a length of 18in and a diameter of 3in which would not be large                  
enough to hold the amount of LiAgx zeolite needed.  
These calculations will be repeated for a zeolite that is more dense than LiAgx so that the size                  
of the beds can remain unchanged and interchangeable with other existing beds. Possible             
zeolites to test include 13x and AgA zeolite. The design goal is to fit the proper amount of                  
zeolite in two 18in X 3in cylinders and produce the required amount of oxygen.  
Cost Analysis 
Question:​ Is current design affordable for low resource, clinical settings in Nepal? 
Requirement:​ “Optimally, the device should cost less than 500 USD. Minimally, the device must 
cost less than 1,600 USD” 
 
The design driver “Is current design affordable for low resource, clinical settings in Nepal?” was               
developed to ensure that design decisions aligned with the high priority requirement that the              
solution should be cost-effective. Specifically, the device should cost less than 500 USD,             
optimally, and the device must cost less than 1,600 USD at a minimum. To address this design                 
driver, cost analysis was performed on the ideal, current oxygen concentrator design as shown              
below in ​Figure 18 on page 27. The cost analysis displayed in the bill of materials operates on                  
the assumption that sourced components direct from suppliers and in the consumer            
after-market are similar in price to what they would be if we were to produce our design at a                   
large scale. This assumption is not entirely accurate, however, meaning our final calculated cost              
for the design will be higher than if we were to mass-manufacture our design (as costs would fall                  
with larger production quantities and more components being sourced either directly from            
manufacturers or manufactured in house). 
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Flow rate Air (L/sec)  1.33 
Product Throughput kg O2/h/kg adsorbent  0.1 
Total Pure Oxygen from LiAgX  10 




Figure 18: ​Cost Analysis of Current Design 
 
A cost analysis was performed on the ideal, current design, sourcing the most important and               
expensive components. Estimates were also driven by benchmarking components and          
materials to find the least expensive part estimates. The resulting total cost estimate is $932.99               
USD, failing the ideal specification of less than 500 USD, but meeting our minimum cost               
requirement of 1600 USD. We expect this total cost to be lower in reality, due to many                 
components not being sourced directly from suppliers. This mode of analysis is effective in              
proving whether we hit our cost requirement, taking into account all major system components              
as well as lower priority parts. The emphasis on internal component costs and detail in the cost                 
analysis was chosen to illustrate both the most essential pieces of the design and their               
respective weight of the total product cost. The most important system components tend to be               
the most expensive, as shown in the cost analysis. 
 
The consequences of this cost analysis are varied. We estimate that we are in the middle of our                  
two cost goals- meeting the minimum requirement but falling short of the ideal. We plan to move                 
our estimate closer to the ideal price of 500 USD by taking a closer look at the materials and                   
whether there are less expensive options, finding more information on other sources of             
components, and verifying the amount of zeolite necessary for effective oxygen concentration.            
Because the sieve beds and the blower are the most expensive components, more             
benchmarking of these products will be done to look for less expensive options. Further detail               
will be added to the cost analysis by estimating reduction in cost of the product because of                 





A weight analysis was performed synchronously to the cost analysis, providing an estimated             
weight of 43.5 lbs. This estimate is lower than the specified <30 kg (~66 lb), meeting the                 
‘transportable by a single person’ requirement for the design. The bulk of this weight estimate               
stems from the large weight estimate of the zeolite beds. Our estimate for the weight of these                 
beds is driven by the quantity required to effectively purify the air derived in the sieve bed                 
analysis. Our next steps include verifying our sieve bed calculations to ensure the current              
zeolite quantity is correct and that our resulting weight estimate is reasonable. The current              
weight estimate leaves wiggle room in the design in terms of materials and extra components               
(ie. adding more user interface components). We will use this information in addition to the cost                
estimate to tweak our design within the bounds of the required cost and weight to be the most                  
efficient in both oxygen performance, safety, and usability. 
Risk Analysis 
Question:​ What are the risks associated with a portable VSA oxygen concentrator? 
Requirement:​ Solution Neutral Considerations 
The next analysis that was performed for the oxygen concentrator was the risk analysis. The               
risk analysis was performed in order to address the question of what risks are associated with a                 
VSA oxygen concentrator. In order to analyse the risks, a FMEA model, or failure modes and                
effects analysis, was used as shown in ​Figure 19​. A hazard analysis was also done in order to                  
review some of the potential hazards associated with the oxygen concentrator shown in ​Figure              
20​. The FMEA was used because it helps to review as many components, assemblies, and               
subsystems as possible in order to help identify potential failure modes in a system, as well as                 
analysing their causes and effects. This is the appropriate mode of analysis because it goes into                
great detail and analyses individual components where failure might occur. This level of detail              
was chosen so that we can find out which individual components are actually in a failure mode,                 
and focus on those. With this information from the FMEA analysis, we can then recommend               
actions that can be taken to to combat and prevent that failure mode. These analyses are                
theoretical at the moment as we do not have a prototype yet. The following figures show the                 





Table 8: ​FMEA Analysis 
 
Table 9: ​FMEA Hazard Analysis 
 
The two tables above show the FMEA analysis for the VSA oxygen concentrator. These tables               
illustrate the fail states of the individual components within the concentrator, as well their              
functions, and actions that can be taken to prevent failure. Potential hazards associated with the               
oxygen concentrator are also shown. The severity of the failures are also shown, ranging from 1                
to 10, 1 being the lease sever and 10 being the most.  
 
The results from the risk analysis indicate that we have to focus heavily on the valve connectors                 
and the oxygen tank, the VSA bed, and making sure that the device is powered properly. This is                  
extremely important in order to avoid a fire hazard. The device contains concentrated oxygen              
which is highly flammable, so we need to take the proper precautions in order to avoid this. The                  
results of these analyses will impact the design by having us focus on protecting the oxygen                
tank as well as protecting the compressor. Also, based on our risk analysis, we should include                
oxygen sensors as well as nitrogen sensors and incorporate circuit breakers and insulation for              
the tank and wiring. The next steps that we plan to take for the risk assessment is to benchmark                   
with an oxygen concentrator and see where failure modes are, and what improvements can be               






Question:​ What errors does an untrained user make interacting with the user interface? 
Requirement:​ ​“The device should be usable after a 5-minute training video” 
As a result of Expert Interview 1 with experts from the clinical simulation center at the University                 
of Michigan, we determined that a physical usability analysis would be necessary to find ways to                
minimize user response time and user error.  
To do a physical usability analysis, we created a cardboard mock-up of the concentrator. The               
mockup featured two moveable sliders for adjusting oxygen concentration and flow rate, as well              
as an imitation of the warning lights and display ​Figure 21​.  
 
Figure 19​: Usability Analysis Mock Interface  
Seven untrained students between the ages of 18 and 22 were asked to complete four tasks                
with the interactive interface. This is a strong feasibility analysis because students with less              
experience than the clinicians who will eventually be using the design. If we are able to proof the                  
device for mistakes with inexperienced and young students, we will also have streamlined its              
use for people more knowledgeable. Additionally, this will mean that clinicians can ask parents              




understaffed. Users were prompted using the following script: 
1. The patient needs to be switched to a nasal cannula. Can you adjust the flow rate? 
2. Set the oxygen concentration to the maximum concentration value. 
3. Does the zeolite filter need to be replaced? 
4. Set the device to the lowest achievable flow rate. 
The results are listed in ​Figure 22​: 
 
Figure 20​: Usability Testing Results 
Participants only made errors in setting minimum and maximum settings. They found the             
interface otherwise clear and easy to react to. Based on participant feedback and the results               
presented in ​Figure 22​, four changes will be made to the final design: 
1. There will be no unachievable values on the slider scales 
a. O2 Conc. Max Slider Value will be: 93% 
b. Flow Rate Min Slider Value will be: 0.5 LPM 
2. There will be a flow on/off switch.  
3. Arrows will be added to the flow rate sliders scale to indicate acceptable use ranges for 




Detailed Design Solution 
The detailed design solution has been developed in CAD, including dimensions, internal            
components, and user interface design in ​Figures 9-12​. This design builds off of the selected               
VSA concept. 
            
Figure 21: ​Front view of Oxygen Concentrator    ​Figure 22: ​Rear view of Oxygen Concentrator 
 
            






Figure 25: ​Oxygen Concentrator Dimensions (Handle Down) 
 
 
Figure 26: ​Oxygen Concentrator Dimensions (Handle Up) 
 
In Figures 21-26​, a 3D model of the current portable oxygen concentrator design is              
presented. This model mainly focuses on the internal components and how they fit together              
inside the transportable device’s packaging. The sides of the device are left transparent to allow               
visibility of the components inside the device, however these sides do exist in the current design                
with the same material as the rest of the external packaging. The air enters the system via the                  
air intake and blower shown in Figure 25. The air is then filtered through a parallel system of                  
zeolite beds and nitrogen is absorbed and removed from the air. The nitrogen exits the device                
via the pneumatic actuator and exhaust located at the top of the design. The now concentrated                
oxygen continues throughout the system to an air mixer, then through to the output in the form                 




exhaust vents, and at the front of the device, there is a christmas tree connector which will be                  
used to connect the oxygen to the ventilation device. The christmas tree connector allows air to                
be delivered to a variety of devices that will distribute air to the patients. There is also a mock-up                   
of the current user interface design included in front of the device. Sliders are included for                
control of the flow rate and the oxygen purity level exiting the device. Sliders were chosen after                 
feedback from a concept generation activity with our peers. Sliders allow the user to quickly               
move to the desired setting and with a slider there is no uncertainty of which way to                 
increase/decrease, a problem using a knob may present. A digital screen is also included for               
additional user feedback, including alarms and system diagnostics. In Figure 22, we can see              
there is a door at the back of the device to allow easy access when servicing the device. The                   
zeolite beds are in the back of the device so they can be replaced easily via the door. This                   
design decision was made as zeolite beds must be replaced annually, as the filters degrade               
over time. Figure 23 shows a side view of the device. This view shows how all the parts of the                    
VSA system fit into the device while at the same time keeping it transportable. The empty space                 
is left open for the controls/user interface and the power supply. In the figures, the device is                 
presented multiple times with either the handle up or down. This shows the retractable              
functionality of the handle and in Figures 25 and 26 a size comparison is made of the device                  
when the handle is down as opposed to up. The dimensions of the device are 26.8 inches x 8.9                   
inches x 12 inches, just over 2 feet in height allowing portability. Fully extending the handle                
brings the height of the  device to about 36 inches. 
 
 
         
       Figure 27: ​Air Intake          ​Figure 28: ​Zeolite Beds               ​Figure 29: ​Air Mixer 
         





The figures shown above present a close up of some of the individual components of the                
VSA system. Figure 27 shows our air intake and behind it there is a silica gel bed which is a                    
filter that removes moisture from the air as it enters the system to increase efficiency of the                 
zeolite. In Figure 28, shown are the zeolite beds and in Figure 30 we show a close up of the                    
valve assembly at the top of the beds, which allows us to control which bed provides oxygen to                  
the patient and which one is being emptied using the pneumatic actuator shown in Figure 31.                
The actuator creates a vacuum which will create an airflow out of the bed into the exhaust.                 
Before reaching the patient the oxygen rich air will go through an air mixer that allows us to                  
control the concentration of oxygen by reintroducing ambient air if the concentration needs to be               
lowered. The air then goes through a flow regulator that lets us control the flow rate.  
Verification 
The overall compliance of our design solution with respect to the requirements and             
specifications was tested with a series of expanded engineering analyses and new verification             
tests and plans as shown below in ​Table 8​. Overall, the majority of our high priority                
requirements have been met. The requirement “Be able to provide sufficient oxygen” is not fully               
verified as the amount of zeolite necessary to filter the air sufficiently has been determined, but                
the resulting cycle time from this amount of zeolite has not been verified. Test plans have been                 
developed to further validate the flow rate and sufficient oxygen levels of the design as well as                 
cycle time of the VSA system. The medium level and lower level requirements have not been                
fully verified, as we spent most of our time focusing on the higher level priority requirements.                
These requirements could be verified easily with a working prototype and corresponding            
experimental tests with the device. Overall, we have a medium level of confidence in our design,                
as our high priority requirements are at high levels of verification, making up for the               
requirements that have been less defined. Additionally, through our research and stakeholder            
meetings, we have not run into significant pushback or criticisms of the important components of               




Table 10. Verification of Final Design  
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Requirement  Specification  Analysis  Result  Verification 
Be able to provide 
sufficient oxygen Provide 93% Oxygen 
Calculation of 
zeolite needed to 
purify to 93% at 10 
LPM flow rate 
11 kg of LiAgX needed,  
2 3”x18” cylinders 
Validation of cycle time 
needed  
 
Be cost-effective Cost: < $500;  < $1600 (Min.) Cost analysis System Cost: $1400  
Be able to maintain a 
low flow rate 
Flow Rate between 




Adoption of current 





Requirement:​ ​“Be usable by a minimally trained user” and “Device maintenance should be 
simple” 
The original user interface of the final design solution had three main features: 
1. Two sliders to control the oxygen concentration and flow rate of delivered oxygen 
2. Three red/green light indicators sharing intake, silica gel filter, and zeolite filter status 
3. A screen to show current oxygen concentration and flow rate 
In the usability analysis, the users tested made errors related to the two sliders.  
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Be usable by a 
minimally trained user 
Simple to use and 
maintain Usability Study 
Sliders for input 
Screen for output 
R/G Warning lights and 
sounds 
 
Be Safe Meets approval guidelines for USFDA 
Planned: FDA 
Clinical Testing ---  
Be able to operate in 
a variety of extreme 
environments 
common to Nepa 
The device must 
operate up to 2000m 
above sea level.  
 
10°C < Operating 
Temp < 40°C 
Planned: 
Environmental 
Testing at 90 kPa, 
10°C < T < 40°C 
---  
Be able to start 
working quickly 
Reach 95% of 93% 
FiO2 and 10 LPM 
flow rate in less than 





pressurized air results 
in a startup time similar 
to that of existing 
devices 
 
Be transportable by a 
single hospital staff 
member 
Weighing < 30 kg CAD, Component Analysis Weight 22 kg < 30 kg  
Device maintenance 
should be simple 
Fixable after 5 minute 
training video Usability Study 
Easily accessible 
Zeolite Beds using 
service door 
 
Be quiet Operating noise <50dB 
Planned: Prototype 
run test ---  
Be operable in Nepal Device uses mains power 
Planned: Electrical 





The oxygen concentration slider scaled from 50% to 100% oxygen, although 93% was the max               
achievable concentration. The range between 93% and 100% was marked unusable by red             
hatching. Users still mistakenly used this area, so the oxygen concentration slider was changed              
so that its range was 50% to 93% oxygen. 
The flow rate slider scaled from 0 LPM to 10 LPM, although 0.5 LPM is the lowest achievable                  
flow rate. The range between 0 LPM and 0.5 LPM was marked unusable by red hatching, but                 
the 0 LPM setting was intended to turn the flow off. This was confusing for users. Therefore, the                  
flow rate slider was changed so that its range was 0.5 LPM to 10 LPM, and an on/off switch was                    
added next to the flow rate slider.  
With these changes, five untrained users were asked to complete the four tasks of the usability                
analysis study. None of these untrained users were in the original study pool so as to avoid the                  
factor of previous experience. No users repeated the errors of users in the original study. All                
users performed all for tasks without error, because the errors made previously were no longer               
possible with the new design. Thus, the previous user interface enabled errors, but the updated               
design addressed and eliminated these errors as shown below in ​Figure 34. 
 
Figure 32​: Usability Verification of Updated UI 
 
Due to the coronavirus pandemic, the conditions of both the usability analysis study and the               
usability verification were not ideal. Under ideal conditions where gathering and travel are             




Handbook of Human Factors in Medical Device Design, Chapter 6: Testing and Evaluation was              
referenced to define ideal testing conditions [41]. 
1. The user interface prototype would be higher fidelity, a working early horizontal prototype 
with that would show the full range of the interface 
2. The study participants would have been representative of the mostly likely users of the 
device. The study would have included clinicians with license to practice in Nepal and 
parents of children under 6 months old in Nepal.  
3. To comply with the second change, the study would have been completed in Nepal. 
4. The study would have included at least 10 participants, as there should be no less than 
5 users per user group. Ideally, the study would have included at least 8 users per user 
group. 
Cost Analysis 
Requirement: ​“Be cost-effective” 
One of the high priority requirements of the design is to ‘be cost-effective’; specifically, the 
device should cost less than 500 USD, optimally, and the device must cost less than 1,600 USD 
at a minimum. To verify this requirement, a cost analysis was performed on the ideal, current 
oxygen concentrator design as shown below in​ Figure 35​. This bottom-up cost analysis includes 
the materials cost identified in the previous engineering analysis as well as external costs such 
as assembly/labor and transportation. This cost estimate is about $1400 USD, meeting our 
minimal cost requirement of $1500 USD. The labor estimate was created using the assumption 
of US Labor and international shipping costs for a unit less than 40 kg. 
 





The team met with subject expert, Randy Schwemmin of C-SED to validate our cost analysis. 
Through this interview, we determined that the bottom up approach is not wholly indicative of 
the predicted final product cost. The benchmarked, commercially-available PSA oxygen 
concentrator’s cost includes mark-up for profit by its manufacturer. Thus, comparing the 
bare-bones VSA design cost analysis does not make the most sense, as the two numbers 
describe different things. To resolve this, a similar materials, labor, and transportation cost 
analysis was created for the PSA system, resulting in a cost estimate of about $1900 , a relative 
cost comparable to the VSA cost analysis. This cost was used to create a ratio of 1.05 of the 
PSA concentrator’s bottom-up cost estimate to its advertised cost of roughly $2000 USD. 
Assuming, this ratio holds true for similar oxygen concentrators, our VSA design is estimated to 
cost $1475. This total cost is still less than the minimal cost requirement of $1500 USD, thus the 
cost-effective requirement has been verified. 
The cost-analysis has posed many important questions not outlined explicitly in the 
requirements and specifications. Further research into potential cost-saving actions, especially 
regarding the front heavy costs associated receiving certification and validation from reputable 
medical device agencies would be beneficial. A market size analysis of Nepal taking into 
account the lifetime of the device and number of beds in Nepal would provide additional context 
on cost reduction of materials from mass production. A deeper look at the location of production 
is also necessary. Nepal borders both India and China, and production in either of these 
companies would significantly lower both assembly and transportation costs. 
Verification Test Plans 
In an ideal situation, the team would have had enough time and resources to fully validate our 
final design. However, due to the complexity of the project’s subject matter, a compressed 
timeline, and Covid-19 complications, the desired testing and verification were not able to be 
completed. The plans for these projected tests include testing of a PSA portable oxygen 
concentrator, of that POC retrofitted to a VSA system, and testing maintenance of the system. 
These testing plans would create a more complete verification of the final design, and, thus, 
higher confidence in the final design. 
PSA Test Plan 
Requirements: ​“Be able to maintain a low flow rate” and “Be able to provide sufficient oxygen” 
We had planned to test the performance of the acquired PSA portable oxygen concentrator, the               
Oxygen Concentrator MAF015AW ​from TTLIFE, to create a benchmark to compare the            
retrofitted VSA system to. The test plan is outlined below and includes testing of the device ‘as                 
is’ from the supplier. 
 
I. Objective​: Test Flow Rate of the POC 
a. Procedure 




2. Wait ten minutes for the machine to reach full performance, then measure            
the flow rate of oxygen output with the flowmeter tool. 
3. Repeat steps 1 and 2 for flow rates 1-6 L/min. 
b. Data Analysis 
1. The measured flow rate with the flowmeter will be compared to the            
displayed flow rate on the user interface to verify the system’s internal            
measurement accuracy 
II. Objective​: Test Oxygen Purification Levels of the PSA portable oxygen concentrator 
a. Procedure 
1. Turn on the device, setting flow rate to 1L/min.  
2. Record the oxygen purity level of the device’s output every 15 seconds for             
the first ten minutes of operation via oxygen concentration content tester           
meter. 
3. Turn off device, waiting at least ten minutes between trials, and repeat            
steps 1 and 2 until three trials have been completed. 
4. Repeat steps 1-3 for flow rate settings of 1-6L/min. 
b. Data Analysis 
1. The data collected in the above test will be compared to the machines             
given operating oxygen concentration levels (30-90%) and, eventually,        
similar data taken from the VSA prototype. 
VSA Test Plan 
Requirements: ​“Be able to maintain a low flow rate” and “Be able to provide sufficient oxygen” 
Ideally, the team would have had sufficient time and resources to fully complete verification with 
the build of a working VSA portable oxygen concentrator prototype. The compressor of the 
purchased PSA concentrator would be removed, and a pneumatic actuator would be added to 
generate the cycling of air through the zeolite beds. The VSA prototype would then be tested 
similarly to the original PSA system, and its performance would be analyzed to verify flow rate 
and oxygen purification requirements. 
III. Objective​: Test Flow Rate of the POC 
a. Procedure 
1. Turn on the device, and set flow rate to 1L/min. 
2. Wait ten minutes for the machine to reach full performance, then measure            
the flow rate of oxygen output with the flowmeter tool. 
3. Repeat steps 1 and 2 for flow rates 1-6 L/min. 
b. Data Analysis 
1. The measured flow rate with the flowmeter will be compared to the            
displayed flow rate on the user interface to verify the system’s internal            
measurement accuracy. Discrepancies between these two measurements       
will be compared to those recorded in the PSA system previously. If the             
prototype successfully operates at 1L/min, the ‘Be able to maintain a low            




IV. Objective​: Test Oxygen Purification Levels of the PSA portable oxygen concentrator 
a. Procedure 
1. Turn on the device, setting flow rate to 1L/min.  
2. Record the oxygen purity level of the device’s output every 15 seconds for             
the first ten minutes of operation via oxygen concentration content tester           
meter. 
3. Turn off device, waiting at least ten minutes between trials, and repeat            
steps 1 and 2 until three trials have been completed. 
4. Repeat steps 1-3 for flow rate settings of 1-6L/min. 
b. Data Analysis 
1. The data collected in the above test will be compared to the data taken              
from the original PSA concentrator. If the prototype reaches 90%+ oxygen           
purity, the ‘Be able to provide sufficient oxygen’ requirement will be           
verified. However, if this value is not reached by either the PSA or VSA              
concentrator, and the two devices’ oxygen outputs are similar, the          
requirement will be partially verified under the assumption that the max           
concentration is reached by both of these systems, and thus the VSA            
system is capable of performing to the researched 93% oxygen levels of            
PSA systems. 
V. Objective​: Test Cycle Times of the POC 
a. Test the cycle time of the POC by removing one of the beds to create a view of                  
when flow is entering and exiting the remaining bed. The timing of this cycle              
would be recorded to further validate the oxygen concentration requirement, as           
well as the ‘Be able to start working quickly’  requirement. 
 
Maintenance Test Plan 
Requirements: ​“Device maintenance should be simple”  
In order to meet this requirement, the oxygen concentrator must be able to be maintenanced 
with no specialized tools and by a technician after a five minute training video . The simplicity of 
the maintenance can be tested by conducting tests changing the filters and zeolite beds and 
recording technician performance. 
 
VII.  ​Objective​: Test Simplicity of the Maintenance 
b. Procedure 
1. Have a group of biomedical technicians, clinicians, and other relevant          
users watch a five minute training video on routine device maintenance. 
2. Rate the performance of each user in the completion of two tasks: filter             
removal and replacement and zeolite bed replacement of prototype based          
on number of errors and time taken to complete tasks. 




1. Analyze performance of users and ease of tasks to fully verify the device             
maintenance requirement. 
Clinician Critique 
The oxygen concentrator is designed to use it in a clinical setting. Under ideal conditions, we                
would have set up interviews with clinicians at the University of Michigan (and potentially low               
resource hospitals) to gain their input on the final input of the design. These interviews would                
include a structured, repeatable agenda with specific questions on parts of the design such as               
the user interface and exterior shape and features to facilitate design changes. 
 
IX.  ​Objective​: Improve the design with clinician feedback  
d. Procedure 
1. Allow clinicians to review the design and use a potential prototype.  
2. Structure a meeting with clinicians and present them with our design idea            
and have a prototype for them to test. 
3. Have them fill out a survey or short report on what they liked about the               
interface and the concentrator and what can be improved. 
e. Data Analysis 
1. Examine the feedback that the clinicians gave and incorporate them into           
the design or modify the concentrator for ease of use.  
Discussion and Recommendations 
Design Critique  
The theoretical design was modeled on existing pressure swing adsorption systems, with the             
intention to take an existing system and retrofit a vacuum swing adsorption system to develop a                
working prototype. Because existing systems work so well and are available in Nepal, the              
design was conceived mainly to lower cost in an effort to increase accessibility. Using this               
redesign of current systems approach, the effect of any cost reduction can be understood by               
researching existing systems. The cost of components can be directly compared with            
components in current systems while operating under the assumption that testing and supply             
chain costs would likely match that of other systems. This way, any reduction in the cost of                 
components acts as a good indicator that the new design reduces the overall cost of the                
concentrator, which must include all overhead and shipping costs. 
While this redesign approach gives increased clarity in cost analysis, the fully theoretical nature              
of the design makes a critique of the design difficult. In a practical scenario, problems and                
insufficiencies would be able to be found and traced, and testing the output of the system would                 
make it easily clear what updates the system needs. If the oxygen output were too moist, it                 
would be evident that more silica gel would be necessary to maintain that flow rate. If                




With a fully theoretical design, none of the calculations done are verifiable in practice. It is hard                 
to identify inefficiencies (like the use of too much zeolite) or insufficiencies. While a computer               
simulation may often help validate theoretical designs, expert interviews with PhD candidates in             
the UM Chemical Engineering department shared that modeling of zeolite adsorption processes            
is extremely difficult and highly imprecise, so all previous research on these processes has              
been experimental. 
To best create a portable oxygen concentrator design, it would have been necessary to create a                
working prototype of the device and a prototype of the zeolite adsorption process alone and               
heavily vet these prototypes to ensure device performance and oxygen concentrations match or             
exceed theoretical calculations. It would also be helpful to fully break down the cost and               
components of current systems, as current systems fully meet the medical needs of patience,              
just at too high of a cost. Such a full breakdown might help identify inefficiencies in current                 
systems and allow more targeted redesigns of the inefficient subsystems, which must be where              
the cost reduction will come from, as the costs of obtaining FDA approval or a CE mark and                  
shipping costs will not be able to be different between systems.  
Future Modifications 
The team’s priority when designing the oxygen concentrator was largely focused on cost. As a               
result, the design is very minimal and does not contain all of the components that may have                 
been necessary to ensure performance comparable to that of existing concentrators.  
 
For example, the design does not include an oxygen surge tank. Although it is not necessary for                 
the concentration of oxygen, it is useful in providing a continuous flow of air. While the system                 
switches between active sieve beds, the tank is essential in preventing fluctuations in flow rate.               
Similarly, a feed buffer tank may also improve performance as it provides a constant supply of                
air to the beds in case of an unexpected reduction in air supply.  
 
Future modification may also include changes in zeolite type. Our calculations are based on              
LiAgX zeolite because that was the compound with the most data we had access to. However,                
the most common carbon molecular sieve on the market today is 13X zeolite. Although the               
performance of our concentrator depends largely on the type of zeolite used, it may prove to be                 
more cost efficient to use a zeolite type currently accessible to hospitals in Nepal.  
 
Another possible modification involves the filtering system placed before the sieve beds. The             
current design only has a silicon filter which is useful for removing moisture from the intake flow.                 
The removal of water is critical to extending the life of the beds and the system as a whole;                   
however, there is no system in place to remove particulate matter. The addition of a High                
Efficiency Cyclone filter followed by a High Efficiency Particulate filter, although more costly,             





These suggested modifications to our vacuum swing adsorption system operated portable           
oxygen concentrator are not necessary for the device to function but may be added to improve                
efficiency, performance, and possibly cost.  
Recommendations 
Given the theoretical nature of the project completed by a fully remote team, there are several                
recommendations that apply to the design presented.  
An operational prototype of the vacuum swing adsorption system should be built and tested to               
verify that the full range of oxygen concentrations can be maintained at all flow rates between                
0.5 LPM and 10 LPM. The prototype could be tested with all five potential modifications listed                
above to compare for improved performance. A separate operational prototype of the user             
interface should be tested per the explanation of the ideal usability verification on page 37: in                
the environment of a controlled study with clinicians and parents. Once both of these systems               
are optimized and functional, a high fidelity prototype should be made and tested according to               
the procedures listed in solution verification. 
With a working prototype presentable as the design solution, cost analysis should be repeated              
with the goal of understanding the cost of manufacturing and getting a CE mark or FDA                
approval. Any reduction here with respect to location of the manufacturer or funding to undergo               
FDA testing would have a significant cost impact on the oxygen concentrator.  
Finally, in order to ensure that the fully working prototype meets all requirements, including ease               
of use and maintenance, it would be best to take the device to Nepal and work with clinicians                  





Creating a portable oxygen concentrator for a clinical, low resource setting is a unique and               
difficult problem that addresses a worldwide need for effective, affordable solutions, especially            
during the Covid-19 pandemic. To address this we have created a robust problem definition,              
and in the interest of capitalizing on our technical mentor’s experience with low resource              
hospitals in Nepal, we have written our requirements and specifications with the more narrow              
use case of neonates in a clinical setting in Nepal. We have identified the oxygen concentration                
method as the most vital component of the proposed solution; and, we have employed concept               
generation strategies such as a morphological chart and TRIZ triggers to produce five unique              
concepts. Through an evaluation process supported by a Pugh chart, vacuum swing adsorption             
(VSA) was selected as our final oxygen concentration method​. ​The concept has been analyzed              




bed analysis, cost analysis, risk analysis, and usability testing and analysis. From the results of               
these analyses, the design of the portable oxygen concentrator has shifted to include a more               
robust design composed of distinct internal system components and a comprehensive user            
interface design. The current design is illustrated by a detailed CAD model. We completed a               
theoretical concept validation with a focus on vacuum swing adsorption feasibility for our             
application, subject matter input and feedback, and expansion of our engineering analyses. The             
final design has been validated to a medium confidence with verification of most of the high                
priority requirements and less verification of the lower priority requirements and specifications. A             
continuation of this project would require construction of physical prototype, physical validation,            
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Appendix A - Design Detail 
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DR1 Requirements and Specifications 
 








Engineering Specification  Priority  Source 
Be able to provide 
sufficient oxygen 
The concentrator must provide 93% FiO2 with a 3% 
contingency. 
High  31, pg 7 
Be able to maintain a 
low flow rate. 
The concentrator’s minimal flow rate must not be higher 
than 2 LPM 
High  31, pg 7 
Modular  The device must easily and modularly interface with a 
broad variety of ventilators and pumps, nasal cannulas, 
masks, etc, used in-country 
High   
Be usable by a 
minimally trained user 
The concentrator must clearly visually and auditorily share 
the current state of oxygen concentration and warnings 
pertaining to patient health and device condition. 
 
No specialized tools may be required for day to day 
operation.  
 
The device should be usable after minimal training time. 
High  31, pgs 
7 & 8 
Be safe.  The device must meet either approval guidelines for 
USFDA or other stringent regulatory body of a founding 
member of IMDRF  
High  31, pg 7 
Be durable.  The device should need maintenance less than 1 time a 
year. 
 
The device must operate above 2000m above sea level. 
 
10°C < Operating Temp < 40°C 
 
15% < Operating Relative Humidity < 95% 
 
The device must meet ISO 13485:2015 (Quality Standard) 
High  31, pgs 
7 & 8 
Be able to start working 
quickly. 
The concentrator must be able to reach 95% of 93% FiO2 
and 10 LPM flow rate in less than five minutes. 
Medium  31, pg 7 
Be transportable by a 
single hospital staff 











The unit must be movable with at least 2 wheels 
Be cost-effective.  Optimally, the device should cost less than USD 500. 
 
Minimally, the device must cost less than USD 1600. 
Medium  31, pg 8 
Device maintenance 
should be simple. 
No specialized tools required. 
 
Fixable by a minimally trained technician. 
 
Filters are easy to wash and replace. 
 
The device must not require preventative maintenance 
more than one time per year.  
Medium  31, pg 8 
Be quiet  Ambient operating noise < 50 dB  Low  31, pg 7 
The device must be 
operable in most 
countries. 
The device uses Mains Power.   
Power Consumption <275W at 5 LPM  
The Voltage Model must match the voltage and frequency 
of the purchasing country’s local power grid. 
Low  31, pg 8 
 
 
Appendix C- Supplemental Appendix 
Engineering Standards 
Engineering standards were only used indirectly on this project, and were not heavily             
referenced.  
One of our set requirements directly references a standard: ISO 13485. This standard speaks              
on the quality management of medical devices. Because we did not bring the project to the point                 
of usable prototype with a manufacturing and maintenance plan, we did not actively apply this               
standard.  
Despite the lack of progress to reach application of this quality standard listed in our               
requirements, we did apply information from the American Standards Association’s standards           
on human noise exposure to set the appropriate decibel level of device warning system to meet                
our requirement “Be usable by a minimally trained user”. 
Aside from these two instances, our project did not use standards for two reasons. First,               
standards provide engineers a common language across stakeholders for a project. We were             
already provided this common language by the Target Product Profile [31] created by the World               
Health Organization and NEST 360, and so we did not end up needing the language of                
standards to create our requirements. We chose instead to stay within the bounds of the Target                
Product Profile referenced by our stakeholders to set requirements. Second, in our initial             
research it became clear that many existing portable oxygen concentrators are either CE or              
FDA approved and meet a variety of standards, as well as most of the requirements of the                 
Target Product Profile [31]. Despite considering more drastic designs that would have required             
a ground up approach, we settled on a design that was based on modifications to current                
pressure swing adsorption oxygen concentrators. Therefore, rather than identifying standards          
from the ground up, it would be necessary to consider parts of the concentrator that changed,                
and examine the standards that apply to them. Once the project had reached a point where all                 
necessary modifications were clear, we would have moved on to studying the applicable             
standards.  
Engineering Inclusivity 
Specific steps were taken to promote inclusive stakeholder engagement and make inclusive 
design decisions through the length of the project.  An active effort was put forth to realize that 
interviews with more qualified and knowledgeable experts does not need to be intimidating. 
Meetings with doctors, nurses, and Ph.D level candidates were approached with the intent of 
the team being vocal in voicing their questions and opinions. Additionally, as our project 




power over decisions with real impacts for these people. We ensured that we would take 
responsibility for the safety that the decisions I make afford these people. This is evident in our 
‘solution-neutral design considerations’ outlined in the problem definition and requirements and 
specifications. Our requirements also included certification by high power medical device 
agencies, providing guidelines for our design to responsibly aid people using our design in 
Nepal. These inclusions of our project were especially important to include, as our device is a 
life-saving device with potentially severe consequences of failure. 
 
Our team practiced inclusive design to a fair extent. We considered several of the key aspects 
of social identities of our teammates, including that each of us have multiple identities, that we 
have flexible identities, and that our identities can be both visible and invisible. With our 
identities considered, we were able to fully identify the social power that our actions and design 
decisions had and the inherent biases that we each had that potentially could persuade 
important decisions. To make our design more inclusive we could have reached out to a greater 
sphere of stakeholders including those who are not necessarily experts. This greater range of 
representation would provide the team with a better perspective on problem definition and more 
inclusive requirements, leading to an overall more inclusive final design. 
Environmental Context Assessment 
 
When making design decisions, thinking environmentally should be a top priority. Our design             
incorporates to the best that it could be done. The components are packed into the device                
housing as tightly as possible to reduce waste in packaging and conserve material used by the                
device. When it comes to sustainability, our device does meet the first two necessary conditions               
required for sustainable technologies. The first requirement is that the solution should make             
progress towards a social or environmental goal. Our solution was made for low resource              
settings so we were meeting a social goal by making a necessary technology more accessible               
to a group of people. Our solution does this by reducing the cost of the device as much as                   
possible and takes into consideration the usability of the device by the people in these settings.                
The second requirement is that the device should not have the potential to lead to undesirable                
consequences in its lifecycle that would outweigh the benefits. Our device does not have that               
potential. It is a scale down of an already existing oxygen purification method and does not use                 
any novel components. This oxygen purification method is already in use at larger scales and               
provides a longer life to the device. The device can be easily serviced which also increases the                 
life of the device which in the long run reduces waste. 
Social Context Assessment 
Designers should consider the social and economic context of technologies when doing design             
work. This is true for our design as well. Our system is likely to be adopted and self sustaining in                    




affordable than anything that is currently out in the market for portable oxygen concentration.              
This will have a major social impact, especially in low income and low resource countries.  
 
This oxygen concentrator design will help many people, as one of the main goals is to minimize                 
cost. At the end of the day, this design is for the common good.This will allow a lot of                   
impoverished families and low income hospitals to have access to better quality healthcare,             
ultimately leading to a better quality of life for these people.  
Ethical Decision Making 
Ethical decision making is when designers consider the ethical responsibilities of their design             
work and evaluate the potential ethical impacts of their designs. The engineering Code of Ethics               
was followed when creating this design. The main goal with this design was creating a low cost                 
oxygen concentrator for low income environments. This goal held the fundamental principle of             
human welfare at its core. 
 
These ethics were incorporated into the major design decisions for this project. The usability,              
affordability, and overall accessibility of this oxygen concentrator were prioritized for all aspects             
of the design process. It is our duty as engineers to put the safety and needs of the people                   
using our designs first. We approached our space with these ethical values in mind. We also                
prioritized the environmental impact of our device and tried to make it as safe as possible, not                 
only to the environment but the user as well. The components are packed into the device                
housing to reduce waste in packaging and conserve material used by the device. Our solution               
minimizes the cost associated with producing such a device, these savings are then passed on               
to the consumer, creating a low cost and easily available solution to portable oxygen              
concentration.  
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